Workflow
片仔癀温胆片Ⅲ期临床试验完成首例受试者入组

Core Viewpoint - The company Pianzaihuang has announced the initiation of Phase III clinical trials for its innovative traditional Chinese medicine, Wen Dan Pian, aimed at treating mild to moderate generalized anxiety disorder [1] Group 1: Clinical Development - Wen Dan Pian has completed the enrollment of the first subject in a multi-center, randomized, double-blind, placebo-controlled Phase III clinical trial [1] - The trial evaluates the efficacy and safety of Wen Dan Pian in treating generalized anxiety disorder characterized by phlegm-heat disturbance [1] Group 2: Product Background - Wen Dan Pian is derived from the classic formula Wen Dan Tang, known for its effects in regulating qi, resolving phlegm, and calming the mind [1] - The product has been used clinically as a hospital preparation since 2007 [1]